Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Office of Criminal Investigations Most Wanted Fugitives

Office of Criminal Investigations Most Wanted Fugitives

                        Office of Criminal Investigations (OCI) Most Wanted Fugitives Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Criminal Investigations
          Office of Criminal Investigations Most Wanted Fugitives
          Office of Criminal Investigations (OCI) Most Wanted FugitivesOffice of Criminal Investigations Most Wanted Fugitives Office of Criminal Investigations (OCI) Most Wanted Fugitives
  
  	
    Share
    Post
    Linkedin

    Email
    PrintFDA-OCI shield

Fugitive Profiles

Help bring these fugitives to justice and protect the health of all citizens.



Back to the Most Wanted Fugitives homepage







WANTED
	OCI Most Wanted: Rajendra Singh KANYAL
**Report Fugitive**

Rajendra Singh KANYAL

Summary of OCI Investigation:

From about 2012 to November 2016, in the Western District of Pennsylvania and elsewhere, Rajendra Singh KANYAL and others defrauded the U.S. Food and Drug Administration (FDA) and the U.S. Customs and Border Protection (CBP) by illegally selling a wide variety of prescription drugs to U.S.-based customers. KANYAL shipped the drugs from India to the U.S. inside of packages containing false customs declarations. These drugs, including Accutane, Paxil, Mifeprostone, Soma, and Tramadol, were controlled substances and drugs that carry an FDA Blackbox warning, which is the FDA’s most serious warning on significant adverse events and contraindications. KANYAL was the owner and operator of Rablon Healthcare, a network of illegal online pharmacy websites that offered to sell prescription drugs to U.S.-based customers. KANYAL used these websites to falsely advertise that the medications that he sold were FDA approved, when in fact they were not.

Also Known As:

Finn Andersan, Finn Anderson, Finn

Date and Place of Birth:

2 July 1981  — Gobrari, India



WANTED
	grigoryan-203x244

**Report Fugitive**

Nuritsa GRIGORYAN

Summary of OCI Investigation:

Nuritsa GRIGORYAN was an unlicensed medical practitioner and wrote bogus prescriptions using an American doctor’s name and license number, and had close relationships with pharmacies and a fraudulent drug wholesale company that were used to funnel prescription drugs back to the pharmacies participating in the scheme. GRIGORYAN generated thousands of prescriptions for identify theft victims, such as elderly beneficiaries of Medicare or Medicaid, military veterans who were also recruited from drug rehabilitation programs, and the homeless. Members of the conspiracy created or doctored patient files to make it falsely appear the drugs were necessary and the patients were legitimately treated. After the prescriptions were filled at pharmacies and paid for by Medicare and Medicaid, they were sold on the black market and redistributed to pharmacies, where the drugs would be subject to new claims made to Medicare and Medicaid as though they were new bottles of drugs.

GRIGORYAN was convicted, via jury trial, on February 18, 2014 of five felonies relating to the adulteration of the pharmaceuticals. She was scheduled to be sentenced in June 2014 and was facing 35 years’ incarceration. On February 24, 2014, GRIGORYAN unlawfully removed her court ordered ankle bracelet and fled. GRIGORYAN obtained another Armenian passport from the Armenian Consulate in Glendale, CA.

Also Known As:

“Nora” GRIGORYAN

Date and Place of Birth:

7 February 1955 — Yerevan, Armenia





WANTED
	Ghandour-203x244

**Report Fugitive**

Hadi Mo GHANDOUR

Summary of OCI Investigation:

GHANDOUR distributed mislabeled and unapproved new drugs, counterfeit human growth hormone and controlled drugs to other distributors throughout the United States. As part of the scheme, GHANDOUR sold 7,938 units of Tiratricol, a potentially life threatening drug producing heart attacks and strokes, in nine months. Further, GHANDOUR purchased insulin vials, graphics for the lot numbers and expiration dates, along with a labelling machine, and mislabeled the vials of the insulin as human growth hormone.

On 9 March 2004, GHANDOUR pleaded guilty to three counts in an indictment before a United States Magistrate Judge for the Western District of Texas. Following his plea, GHANDOUR was allowed to remain on bail until his sentencing date, which was scheduled in the United States District Court for 25 May 2004. The court allowed GHANDOUR to travel to California for his business and then to Florida to visit his family. He was to return to Austin, Texas, on 26 March 2004, and report to officers the following morning. GHANDOUR failed to report as directed and efforts to locate and/or contact him have been unsuccessful.

Date and Place of Birth:

13 February 1971 — Lebanon





WANTED
	Cellou JUMAINE

**Report Fugitive**

**Cellou**JUMAINE

Summary of OCI Investigation:

From between August 2006 and April 2007, Cellou JUMAINE and co-conspirator Alpha Yaya Jalloh were principals of the Fatala Corporation based in New York, which imported approximately 990,000 tubes of counterfeit Colgate toothpaste into the U.S. from China. JUMAINE and Jalloh knew the imported toothpaste was not a genuine Colgate product, and intended to sell it with counterfeit Colgate marks to confuse and deceive customers. Most of the toothpaste contained either no fluoride or significantly less fluoride than that which is found in genuine Colgate toothpaste. In addition, some of the toothpaste contained harmful substances, such as Bacillus bacteria, and diethylene glycol, which is a chemical toxic to humans. The toothpaste contained in all of the shipments was resold by Fatala Corporation to customers in New York and elsewhere.

Also Known As:

Jumaine CELLOU; Cellou B DIALLO

Date and Place of Birth:

02 May 1965 – Burundi

Additional Information:

JUMAINE may currently reside in the Anta neighborhood of the Matoto commune in Conakry, Guinea





WANTED
	bridgmon small

**Report Fugitive**

Abigail BRIDGMON

Summary of OCI Investigation:

From June 2008 to September 2009, in the Central District of California and elsewhere, Abigail BRIDGMON and others used counterfeit markings to sell counterfeit pharmaceuticals over the Internet, including pills that appeared to be OxyContin, Cialis, Viagra, Levitra, Valium, and human growth hormones. BRIDGMON and others recruited individuals as drop shippers to help distribute the counterfeit pharmaceutical drugs throughout the U.S. to customers who ordered the drugs over the Internet. On 7 occasions, BRIDGMON and others caused parcels containing a total of approximately 3,187 counterfeit pharmaceutical drugs to be sent to a drop shipper in California who would then distribute the drugs to customers. In total, the estimated retail value of the counterfeit products shipped to California was approximately $123,000 USD.

Also Known As:

Abigail Miranda BRIDGMON; Tricia LING

Date and Place of Birth:

04 May 1978 - Angeles City, Philippines





WANTED
	jiang small

**Report Fugitive**

Bo JIANG

Summary of OCI Investigation:

JIANG is believed to be the owner/operator of Hua Shun Development Ltd in Auckland, New Zealand, and Shiboliang Foods in China.

From May 2008 to September 2009, in the Central District of California and elsewhere, Bo JIANG and others sold counterfeit pharmaceuticals over the Internet, including OxyContin, Cialis, Viagra, Levitra, Valium, and human growth hormones. Without the proper license, JIANG imported prescription drugs into the U.S., and then recruited and instructed individuals to sell and distribute the counterfeit pharmaceuticals. On at least one occasion, JIANG imported 237 counterfeit pills into the U.S. and, caused 20 packages of counterfeit pharmaceuticals to be shipped within the U.S. On 29 occasions, JIANG and others shipped approximately 17,022 counterfeit pharmaceutical drugs to be distributed to customers in California. The estimated retail value of the counterfeit pharmaceuticals JIANG and others shipped to a customer in California was approximately $123,000 USD.

Also Known As:

Bob JIANG

Date and Place of Birth:

07 June 1978 - Shandong, China





WANTED
	VanRooyan small

**Report Fugitive**

Stephen Mark VAN ROOYEN

Summary of OCI Investigation:

Between spring 2002 and March 2006, in the Northern District of Georgia and elsewhere, Stephen VAN ROOYEN and Laura Brown operated a business named Biomark International, (Biomark), and sold stem cells and stem cell injections to persons suffering from Amyotrophic Lateral Sclerosis (ALS or "Lou Gehrig’s Disease"), Multiple Sclerosis, and other chronic diseases. VAN ROOYEN and Brown claimed that their customersÂ’ diseases could be treated or cured through the use and injection of stem cells that were derived from umbilical cord blood. VAN ROOYEN and Brown charged customers between $10,000 and $32,000 USD for each treatment. VAN ROOYEN and Brown injected each customer in the abdomen with 1.5 million stem cells regardless of their disease. The stem cells acquired by VAN ROOYEN and Brown were solely intended for use in laboratory research on animals and were never intended to be used on humans. VAN ROOYEN and Brown misled their customers by convincing them that the treatments would cure their diseases. VAN ROOYEN and Brown received at least $1.2 million USD in proceeds from this scheme, which they took from Biomark and transferred to their own personal joint bank account.

Also Known As:

BCARLISLE Sebastian; Mark DEHAVILLAN; Stephen Mark Van ROOYEN; Steve V ROOYEN; Stephen VAN ROOYEN; Steve VAN ROOYEN; Stephen VANROOYEN; Stephen Mark VANROOYEN

Date and Place of Birth:

16 January 1962-Capetown, South Africa

                                                                                  Content current as of:
      02/01/2023Office of Criminal Investigations Most Wanted Fugitives

          
                        Office of Criminal Investigations (OCI) Most Wanted Fugitives
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop